You have 9 free searches left this month | for more free features.

11C-MET

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Dosimetry of [11C]CHDI-180R and [11C]CHDI-626.

Completed
  • Huntington Disease
  • [11C]CHDI-00485180-R
  • [11C]CHDI-00485626
  • Leuven, Belgium
    UZ Leuven
May 18, 2022

MDD Trial in Shanghai (Toludivenlafaxine HCl sustained-release tablets)

Recruiting
  • Major Depressive Disorder
  • Toludivenlafaxine hydrochloride sustained-release tablets
  • Shanghai, Shanghai, China
    Shanghai Mental Health Center
Jun 14, 2023

Carcinoma, Hepatocellular Trial in Darmstadt (Tepotinib)

Completed
  • Carcinoma, Hepatocellular
  • Darmstadt, Germany
    Please contact the Merck KGaA Communication Center located in
Aug 22, 2022

Mild Cognitive Impairment Trial in Winston-Salem ([11C]Acetoacetate[18F]Fluorodeoxyglucose positron emission tomography scan)

Enrolling by invitation
  • Mild Cognitive Impairment
  • [11C]Acetoacetate[18F]Fluorodeoxyglucose positron emission tomography scan
  • Winston-Salem, North Carolina
    Wake Forest School of Medicine
Dec 22, 2022

Colorectal Cancer Metastatic, C-met Overexpression Trial in Rozzano (Tivantinib (ARQ197))

Completed
  • Colorectal Cancer Metastatic
  • C-met Overexpression
  • Tivantinib (ARQ197)
  • Rozzano, Milano, Italy
    Istituto Clinico Humanitas
Sep 8, 2022

Endometrial Cancer Recurrent Trial in Tainan (Crizotinib 250 MG)

Recruiting
  • Endometrial Cancer Recurrent
  • Crizotinib 250 MG
  • Tainan, Taiwan
    National Cheng Kung University Hospital
Jun 6, 2022

Amyotrophic Lateral Sclerosis Trial in Baltimore ([11C]CPPC Injection)

Recruiting
  • Amyotrophic Lateral Sclerosis
  • [11C]CPPC Injection
  • Baltimore, Maryland
    Johns Hopkins Outpatient Center
Jul 11, 2022

Solid Tumor Trial in United States (TR1801-ADC)

Active, not recruiting
  • Unspecified Adult Solid Tumor, Protocol Specific
  • TR1801-ADC
  • Los Angeles, California
  • +4 more
Oct 30, 2022

Brain Cancer Trial in New York (PET scan, C-Choline)

Completed
  • Brain Cancer
  • PET scan
  • C-Choline
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 9, 2022

Lymphangioleiomyomatosis, Tuberous Sclerosis Complex Trial in Boston ([11C]acetate)

Recruiting
  • Lymphangioleiomyomatosis
  • Tuberous Sclerosis Complex
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jul 20, 2022

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, biological, drug)

Not yet recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Sep 7, 2023

Lung in Pulmonary Artery Hypertension (PAH)

Not yet recruiting
  • Pulmonary Arterial Hypertension
  • Healthy
  • TSPO PET scan (11C-PBR28)
  • (no location specified)
Feb 16, 2023

Patients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is Available Trial

Completed
  • Patients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is Available
  • Houston, Texas
    M.D. Anderson Cancer Center
Aug 22, 2022

HIV Associated Neurocognitive Disorder, HIV Dementia, HIV Encephalitis Trial (SV2A PET, TSPO PET)

Not yet recruiting
  • HIV Associated Neurocognitive Disorder
  • +3 more
  • SV2A PET
  • TSPO PET
  • (no location specified)
Oct 16, 2022

Alzheimer Trial in Lille, Paris, Rouen ([11C]-UCB-J, [18F]-DPA-714, [18F]-RO-948)

Not yet recruiting
  • Alzheimer Disease
  • [11C]-UCB-J
  • +3 more
  • Lille, France
  • +2 more
Jun 12, 2023

Depression Trial run by the NIMH (11C-MCI, 11CPS13)

Recruiting
  • Depression
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Aberrant Synaptic Plasticity in Cocaine Use Disorder: A

Recruiting
  • Cocaine Use Disorder
  • Healthy Controls
  • 11C-UCB-J
  • New Haven, Connecticut
    Connecticut Mental Health Center
Aug 10, 2022

CS1P1 PET Studies of Neuroinflammation in Parkinson Disease

Not yet recruiting
  • Parkinson Disease
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 10, 2023

Mild Cognitive Impairment Trial in Philadelphia (11C-acetate)

Terminated
  • Mild Cognitive Impairment
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Apr 11, 2022

Advanced Hepatocellular Carcinoma With c-MET Dysregulation Trial in Worldwide (INC280)

Active, not recruiting
  • Advanced Hepatocellular Carcinoma With c-MET Dysregulation
  • Nanjing, Jiangsu, China
  • +7 more
Jan 12, 2023

Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC V7 Trial in Houston (ABBV-399)

Completed
  • Recurrent Squamous Cell Lung Carcinoma
  • Stage IV Squamous Cell Lung Carcinoma AJCC V7
  • Houston, Texas
    M D Anderson Cancer Center
Sep 21, 2021

Healthy Participants Trial in London ([11C]-Lu AF88370)

Completed
  • Healthy Participants
  • [11C]-Lu AF88370
  • London, United Kingdom
    Invicro
Jul 12, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San Francisco

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Computed Tomography
  • +3 more
  • San Francisco, California
    University of California San Francisco
Dec 19, 2022

[18F]Florbetazine for Beta Amyloid PET Imaging in Alzheimer's

Recruiting
  • Alzheimer's Disease
  • Beijing, China
    Department of Nuclear Medicine, Peking Union Medical College Hop
Nov 19, 2023

Multiple Sclerosis (MS) Trial in Ann Arbor, London (11C-BMS-986196)

Recruiting
  • Multiple Sclerosis (MS)
  • Ann Arbor, Michigan
  • +1 more
May 26, 2022